Ottawa, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The global antitumor ADC drugs market size is calculated at USD 8.33 billion in 2026 and is expected to reach around USD 24.75 billion by 2035, growing at a ...
Solid tumors remain largely unresponsive to immune checkpoint inhibitors, in part due to their ability to suppress the cytotoxic activity of immune cells infiltrating the tumor microenvironment. One ...